Delivery Order SPE2DB22D1002-SPE2DB25FKWG5

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,007.51 firm fixed-price delivery order contract is for the supply of 4566926520 - ONDANSETRON ODT 4 MG TABLET 30S, with a period of performance running through January 15, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,264.43 Firm Fixed Price Delivery Order is for the supply of 4567202443 ONDANSETRON ODT 4 MG TABLET 30S, with a period of performance through February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,785.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566758372 ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a completion date of December 19, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $6,726.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567140861 - ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a completion date of February 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $37,962.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566565242 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, and has a completion date of November 29, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $11,170.47, is for the delivery of 4565664125 ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of September 4, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,753.21 firm-fixed-price delivery order contract covers the provision of 4566821126 ONDANSETRON ODT 4 MG TABLET 30S, with a performance completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. government awarded a Delivery Order contract worth $46,689.26 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is to supply 4565665151 ONDANSETRON ODT 4 MG TABLET 30S, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
This federal contract award, valued at $1,459.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ONDANSETRON HCL 8 MG TABLET 30S, a pharmaceutical product, with a performance period through December 24, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $2,554.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566503711 ONDANSETRON ODT 4 MG TABLET 30S, a prescription medication, with a completion date of November 21, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and held by AmerisourceBergen with the DLA...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKWG5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,424.24, is for the delivery of 4566844259 - ONDANSETRON ODT 4 MG TABLET 30S.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:45 AM